Neofect
Innovative home exercise device and software for stroke survivors' fast recovery and rehabilitation.
Launch date
Employees
Market cap
$32.4m
Enterprise valuation
$36m (Public information from Sep 2024)
Share price
KRW925 290660.KQ
Company register number 1198629663
San Francisco California (HQ)
Financials
Estimates*
| KRW | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 4.5b | 5.7b | 12.3b | 18.6b | 23.2b | 26.2b | 26.6b |
| % growth | - | 27 % | 118 % | 51 % | 24 % | 13 % | 2 % |
| EBITDA | (3.7b) | (4.6b) | (11.8b) | (11.5b) | (4.5b) | (4.6b) | 411m |
| % EBITDA margin | (83 %) | (82 %) | (96 %) | (62 %) | (20 %) | (18 %) | 2 % |
| Profit | (4.4b) | (9.6b) | (15.8b) | (15.0b) | (5.0b) | (9.6b) | (5.0b) |
| % profit margin | (99 %) | (170 %) | (129 %) | (81 %) | (22 %) | (37 %) | (19 %) |
| EV / revenue | - | 12.5x | 6.0x | 4.0x | 3.4x | 2.0x | 2.2x |
| EV / EBITDA | - | -15.3x | -6.2x | -6.6x | -17.2x | -11.6x | 143.2x |
| R&D budget | - | - | - | 1.7b | 1.5b | 1.9b | 1.5b |
| R&D % of revenue | - | - | - | 9 % | 6 % | 7 % | 6 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
* | KRW1.0b | Series A | |
* | KRW4.2b | Series B | |
KRW6.0b | Series B | ||
KRW6.0b | Series C | ||
| N/A | N/A | IPO | |
| N/A | N/A | Post IPO Equity | |
| N/A | KRW35.5b | Post IPO Equity | |
| Total Funding | $14.4m | ||
Related Content
Recent News about Neofect
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Neofect
Edit
ACQUISITION by Neofect Jul 2019